​
​

Atossa Therapeutics (ATOS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Atossa Therapeutics Revenue Highlights

00

Atossa Therapeutics Revenue by Period

Atossa Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--100.00%
2015-12-31$1.76K-99.67%
2014-12-31$525.95K-16.85%
2013-12-31$632.56K31.28%
2012-12-31$481.84K32022.80%
2011-12-31$1.50K100.00%
2010-12-31--

Atossa Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Atossa Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$18.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--100.00%
2015-12-31$-5.34M-791.22%
2015-09-30$772.24K-71.34%
2015-06-30$2.69M43.82%
2015-03-31$1.87M283.45%
2014-12-31$488.53K14159.46%
2014-09-30$3.43K-65.31%
2014-06-30$9.88K-59.07%
2014-03-31$24.12K-48.90%
2013-12-31$47.21K-38.36%
2013-09-30$76.60K-76.51%
2013-06-30$326.08K78.51%
2013-03-31$182.67K85.53%
2012-12-31$98.46K-6.74%
2012-09-30$105.58K-52.68%
2012-06-30$223.10K476.97%
2012-03-31$38.67K2477.80%
2011-12-31$1.50K100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2009-09-30--

Atossa Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Atossa Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ONTXTraws Pharma$226.00B$56.00K
NVAXNovavax$983.71M$415.48M
INOInovio Pharmaceuticals$832.01M-
JAGXJaguar Health$9.76M$3.07M
TNXPTonix Pharmaceuticals$7.77M$2.82M
VXRTVaxart$7.38M$4.93M
OCGNOcugen$6.04M$1.14M
PALIPalisade Bio$250.00K-
SONNSonnet BioTherapeutics$147.81K-
CWBRCohBar--
AVROAVROBIO--
ELEVElevation Oncology--
GOVXGeoVax Labs-$300.68K
ATOSAtossa Therapeutics--
OCEAOcean Biomedical--
ENVBEnveric Biosciences--

ATOS Revenue FAQ

What is Atossa Therapeutics’s yearly revenue?

Atossa Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ATOS's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Atossa Therapeutics’s quarterly revenue?

Atossa Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ATOS's quarterly revenue for Q4 2023 was $18K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Atossa Therapeutics’s revenue growth rate?

Atossa Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.